Line 100: | Line 100: | ||
<br> | <br> | ||
− | <img src = "https://static.igem.org/mediawiki/2016/8/8d/T--BostonU--WL_at_MIT.jpg" width = 40% style = "padding:5% | + | <img src = "https://static.igem.org/mediawiki/2016/8/8d/T--BostonU--WL_at_MIT.jpg" width = 40% style = "padding:5% 5% 10% 3%; float:left;"> |
<p style = "color:#0071A7; font-size:150%; padding:0% 8% 3% 5%;">In the beginning of the summer, we collaborated with MIT, specifically their Recombinase team. Several members of our team worked previously with recombinases and used this time to discuss several topics surrounding this body of work. These topics included structures of recombinase circuits, phylogenetic tree of recombinases, as well as the orthogonality of various heterospecific site-recombinase pairs. In addition, we worked with the entire MIT team to prepare for the NEGEM #1 conference, practicing both presentations and responding to audience questions.</p> | <p style = "color:#0071A7; font-size:150%; padding:0% 8% 3% 5%;">In the beginning of the summer, we collaborated with MIT, specifically their Recombinase team. Several members of our team worked previously with recombinases and used this time to discuss several topics surrounding this body of work. These topics included structures of recombinase circuits, phylogenetic tree of recombinases, as well as the orthogonality of various heterospecific site-recombinase pairs. In addition, we worked with the entire MIT team to prepare for the NEGEM #1 conference, practicing both presentations and responding to audience questions.</p> |
Revision as of 03:24, 17 October 2016
In the beginning of the summer, we collaborated with MIT, specifically their Recombinase team. Several members of our team worked previously with recombinases and used this time to discuss several topics surrounding this body of work. These topics included structures of recombinase circuits, phylogenetic tree of recombinases, as well as the orthogonality of various heterospecific site-recombinase pairs. In addition, we worked with the entire MIT team to prepare for the NEGEM #1 conference, practicing both presentations and responding to audience questions.
During NEGEM #1, we mingled with the other teams in attendance to potentially collaborate to improve experimental projects or human practices projects. During NEGEM #1 we discussed with WPI how they were using fluorescent microscopy for their assaying technique, while we used flow cytometry. In the spirit of iGEM and further characterization, we proposed a swap: We would run several WPI samples on our flow cytometer and aid in analysis, while WPI would view and image our circuits under their microscopes. In both cases, we were able to validate that our parts functioned as expected. Specifically, we found that our results were replicable under both assaying techniques.
We collaborated with our fellow home team, BostonU HW (Hardware) to develop one of our Human Practices projects, a blog about intellectual property in synthetic biology and software. Uniformly, we agreed that intellectual property was an important topic to iGEMmers and synthetic biologists at large, and thus the disbursement of this information was critical. The first post was a team effort to introduce our readers to intellectual property, patents, copyrights, etc. and to establish the tone for our blogs. Each subsequent post was then switched off so the wet lab team wrote one week and the hardware team wrote the following week. Of course our bloggers, Castor and Pollux, always edited each other's work before it was uploaded.
On Friday, June 24th, Boston University hosted NEGEM, a meetup for iGEM teams all across New England to gather and share their research work and their plans for the Human Practices and Policies portion of the competition. All of the nine teams in attendance were given 15-20 minutes to present their research project and their plans for their Human Practices and Policies. Every person in attendance was asked to fill out an evaluation form about their research, P&P, and presentation style. The questions ranged from “Is their idea well-motivated?” to “suggestions on ways to integrate research with P&P” to “Was the talk engaging?” After the teams finished their presentations, other iGEMers, HQ representatives, and mentors asked the teams for clarification on their research, future plans for outreach, and some ethical implications of using their project.